Your browser doesn't support javascript.
loading
Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis.
Simader, Elisabeth; Tobudic, Selma; Mandl, Peter; Haslacher, Helmuth; Perkmann, Thomas; Nothnagl, Thomas; Sautner, Judith; Radner, Helga; Winkler, Florian; Burgmann, Heinz; Mrak, Daniel; Aletaha, Daniel; Winkler, Stefan; Blüml, Stephan.
Afiliación
  • Simader E; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
  • Tobudic S; Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Vienna, Austria.
  • Mandl P; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
  • Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Perkmann T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Nothnagl T; Second Medical Department, Lower Austrian Centre for Rheumatology, Stockerau, Austria.
  • Sautner J; Second Medical Department, Lower Austrian Centre for Rheumatology, Stockerau, Austria.
  • Radner H; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
  • Winkler F; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
  • Burgmann H; Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Vienna, Austria.
  • Mrak D; Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Vienna, Austria.
  • Aletaha D; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
  • Winkler S; Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
  • Blüml S; Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Vienna, Austria.
Ann Rheum Dis ; 81(3): 416-421, 2022 03.
Article en En | MEDLINE | ID: mdl-34844927
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Espondiloartritis / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Observational_studies Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Espondiloartritis / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Observational_studies Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article